MARKET STRATEGY AND POSITIONING

Human health spending in the United States is currently at 16% of GDP and is forecasted to grow to 20% by 2015. Over the last decade, innovative new products have been mostly developed by emerging companies, but have been commercialized by global established firms. Scientia Advisors helps companies understand who their customers are. Most likely their customers are not just the end user but also a myriad of potential partners who will ultimately sell to the end user. Therefore a two or more prong strategy must be developed: both the end user and the potential partners for superior market insight.

Scientia Advisors life science focus and experienced team allows us to concentrate our analysis on critical issues, resulting in efficient results. We have a well-defined process for emerging companies, which differs significantly from the process for global companies. Scientia has access to a vast network of experts to facilitate primary research gathering. Although secondary research is sufficient in some cases, primary research results in qualitative and quantitative data points. Both investors and potential partners need focus group analysis and customer surveys to ground their decision making process. Scientia provides strategies that can be implemented and will produce tangible results.

To find out more about Scientia’s work in this capability area, please contact us.